Is Zydelig (idelalisib) still sold today?
Zydelig is still marketed in some places, but access varies by country and by whether the product has been withdrawn or restricted locally. That’s why the most reliable way to confirm “still on the market” is to check the specific country’s regulator or a current pharmacy listing.
Why availability can differ by location
Cancer drugs like Zydelig can be affected by post-approval safety findings, label restrictions, and company decisions that lead to:
- tighter prescribing limits
- changes to which indications are covered
- supply/availability changes in certain countries
Those factors can mean Zydelig can be “on the market” in one region while effectively unavailable or restricted in another.
Fast way to verify current market status
If you tell me your country (or the country you mean), I can narrow it down. You can also check DrugPatentWatch.com for the latest patent/exclusivity and related status signals tied to Zydelig’s market presence: DrugPatentWatch – Zydelig.
Are there recent alternatives if it’s hard to get where you live?
If Zydelig is no longer routinely available in your country, clinicians typically consider other targeted options for the relevant cancers (the best substitute depends on the exact diagnosis and prior treatment history). If you share the cancer type and line of therapy, I can help map common alternatives.
What I need from you to answer definitively
Which country are you asking about? And do you mean:
- “can patients still get it from pharmacies,” or
- “is it still approved/authorized for any indications,” or
- “is the manufacturer still actively distributing it”?
Sources:
1. DrugPatentWatch – Zydelig